Interleukin-35 is upregulated in systemic sclerosis and its serum levels are associated with early disease
出版年份 2015 全文链接
标题
Interleukin-35 is upregulated in systemic sclerosis and its serum levels are associated with early disease
作者
关键词
-
出版物
RHEUMATOLOGY
Volume -, Issue -, Pages kev260
出版商
Oxford University Press (OUP)
发表日期
2015-08-01
DOI
10.1093/rheumatology/kev260
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pro-inflammatory effects of interleukin-35 in rheumatoid arthritis
- (2015) Mária Filková et al. CYTOKINE
- S100A4 amplifies TGF-β-induced fibroblast activation in systemic sclerosis
- (2014) Michal Tomcik et al. ANNALS OF THE RHEUMATIC DISEASES
- Interleukin-35 gene therapy exacerbates experimental rheumatoid arthritis in mice
- (2014) A. Thiolat et al. CYTOKINE
- Interleukin-35 induces regulatory B cells that suppress autoimmune disease
- (2014) Ren-Xi Wang et al. NATURE MEDICINE
- Mathematical Modeling of Interleukin-35 Promoting Tumor Growth and Angiogenesis
- (2014) Kang-Ling Liao et al. PLoS One
- Elevated plasma interleukin-35 levels predict poor prognosis in patients with non-small cell lung cancer
- (2014) Xiaobin Gu et al. TUMOR BIOLOGY
- Interleukin-12 family cytokines and sarcoidosis
- (2014) Sabine Ringkowski et al. Frontiers in Pharmacology
- Decreased Interleukin 35 and CD4+EBI3+T cells in Patients With Active Systemic Lupus Erythematosus
- (2013) Han Ouyang et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative
- (2013) Frank van den Hoogen et al. ANNALS OF THE RHEUMATIC DISEASES
- Review: Evidence That Systemic Sclerosis Is a Vascular Disease
- (2013) Marco Matucci-Cerinic et al. ARTHRITIS AND RHEUMATISM
- 2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
- (2013) Frank van den Hoogen et al. ARTHRITIS AND RHEUMATISM
- Circulating IL-35 in pancreatic ductal adenocarcinoma patients
- (2013) Peng Jin et al. HUMAN IMMUNOLOGY
- JAK-2 as a novel mediator of the profibrotic effects of transforming growth factor β in systemic sclerosis
- (2012) Clara Dees et al. ARTHRITIS AND RHEUMATISM
- The composition and signaling of the IL-35 receptor are unconventional
- (2012) Lauren W Collison et al. NATURE IMMUNOLOGY
- The transcription factor JunD mediates transforming growth factor -induced fibroblast activation and fibrosis in systemic sclerosis
- (2011) K. Palumbo et al. ANNALS OF THE RHEUMATIC DISEASES
- Interleukin-35 Enhances Lyme Arthritis inBorrelia-Vaccinated and -Infected Mice
- (2011) Joseph Kuo et al. Clinical and Vaccine Immunology
- A GWAS follow-up study reveals the association of the IL12RB2 gene with systemic sclerosis in Caucasian populations
- (2011) Lara Bossini-Castillo et al. HUMAN MOLECULAR GENETICS
- Elevated serum interleukin-27 levels in patients with systemic sclerosis: association with T cell, B cell and fibroblast activation
- (2010) A. Yoshizaki et al. ANNALS OF THE RHEUMATIC DISEASES
- Inactivation of the transcription factor STAT-4 prevents inflammation-driven fibrosis in animal models of systemic sclerosis
- (2010) Jérôme Avouac et al. ARTHRITIS AND RHEUMATISM
- IL-35 Stimulation of CD39+ Regulatory T Cells Confers Protection against Collagen II-Induced Arthritis via the Production of IL-10
- (2010) I. Kochetkova et al. JOURNAL OF IMMUNOLOGY
- Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus
- (2010) Timothy R D J Radstake et al. NATURE GENETICS
- IL-35-mediated induction of a potent regulatory T cell population
- (2010) Lauren W Collison et al. NATURE IMMUNOLOGY
- Assessing microvascular changes in systemic sclerosis diagnosis and management
- (2010) Maurizio Cutolo et al. Nature Reviews Rheumatology
- STAT4is a genetic risk factor for systemic sclerosis having additive effects withIRF5on disease susceptibility and related pulmonary fibrosis
- (2009) P. Dieudé et al. ARTHRITIS AND RHEUMATISM
- Interleukin-35: odd one out or part of the family?
- (2009) Lauren W. Collison et al. IMMUNOLOGICAL REVIEWS
- Bosentan increases serum IL-12 levels in systemic sclerosis patients with pulmonary arterial hypertension
- (2009) Yasuhito Hamaguchi et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Scleroderma
- (2009) Armando Gabrielli et al. NEW ENGLAND JOURNAL OF MEDICINE
- The interleukin 23 receptor gene does not confer risk to systemic sclerosis and is not associated with systemic sclerosis disease phenotype
- (2008) B Rueda et al. ANNALS OF THE RHEUMATIC DISEASES
- Dual inhibition of c-abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis
- (2008) Alfiya Akhmetshina et al. FASEB JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started